Weiwei Jiang

2.0k total citations · 1 hit paper
54 papers, 1.5k citations indexed

About

Weiwei Jiang is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Weiwei Jiang has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 14 papers in Immunology and 10 papers in Cancer Research. Recurrent topics in Weiwei Jiang's work include MicroRNA in disease regulation (5 papers), Gut microbiota and health (5 papers) and Immune Response and Inflammation (5 papers). Weiwei Jiang is often cited by papers focused on MicroRNA in disease regulation (5 papers), Gut microbiota and health (5 papers) and Immune Response and Inflammation (5 papers). Weiwei Jiang collaborates with scholars based in China, United States and Hong Kong. Weiwei Jiang's co-authors include Xinyun Qiu, Na Wu, Yulan Liu, Yujing Chi, Ying Hu, Xuemei Wang, Jing Li, Yuanyuan Zhang, Hong Zhou and Jiang Zheng and has published in prestigious journals such as Gut, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Weiwei Jiang

50 papers receiving 1.5k citations

Hit Papers

Dysbiosis gut microbiota associated with inflammation and... 2015 2026 2018 2022 2015 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
    2015 504 citations Weiwei Jiang, Yulan Liu et al. profile →

Peers

Weiwei Jiang
Ravindra P. Veeranna India
Rui Lin China
Yeji Kim South Korea
Yinglei Miao China
Helieh S. Oz United States
Liya Yang China
Luis Fontana Spain
Lanlan Geng China
Woo Sik Kim South Korea
Rohit Gundamaraju Australia
Ravindra P. Veeranna India
Weiwei Jiang
Citations per year, relative to Weiwei Jiang Weiwei Jiang (= 1×) peers Ravindra P. Veeranna

Countries citing papers authored by Weiwei Jiang

Since Specialization
Citations

This map shows the geographic impact of Weiwei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Jiang more than expected).

Fields of papers citing papers by Weiwei Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Jiang. The network helps show where Weiwei Jiang may publish in the future.

Co-authorship network of co-authors of Weiwei Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Jiang. A scholar is included among the top collaborators of Weiwei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Jiang. Weiwei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Sizhen, Jian‐Yu Zheng, Jiao Zhou, et al.. (2025). Engineered lipid nanoparticles with synergistic dendritic cell targeting and enhanced endosomal escape for boosted mRNA cancer vaccines. Materials Today Bio. 34. 102107–102107. 2 indexed citations
2.
Jiang, Weiwei, Wenhan Li, Xuejin Li, et al.. (2025). Developing sodium alginate based edible film incorporated with potassium sorbate and application for fresh cold pork preservation. Food Control. 172. 111154–111154. 4 indexed citations
3.
Huang, Daoyuan, Jingchao Wang, Li Chen, et al.. (2025). Targeting the PARylation-Dependent Ubiquitination Signaling Pathway for Cancer Therapies. Biomolecules. 15(2). 237–237. 1 indexed citations
4.
5.
Jiang, Weiwei, et al.. (2024). Hla protein expression and artesunate prevented mice from further damage caused by Staphylococcus aureus pneumonia. International Journal of Biological Macromolecules. 277(Pt 1). 134099–134099. 2 indexed citations
6.
7.
Wang, Sizhen, Hanzhe Zhang, Tianheng Chen, et al.. (2024). Injectable hyaluronate-L- cysteine gel potentiates photothermal therapy in osteosarcoma via vorinostat-copper cell death. Materials Today Bio. 29. 101368–101368. 1 indexed citations
8.
Lin, Huiling, Ming Zhang, Mi Hu, et al.. (2024). Emerging applications of single-cell profiling in precision medicine of atherosclerosis. Journal of Translational Medicine. 22(1). 97–97. 7 indexed citations
9.
Wang, Chenkun, Hongwei Li, Tao Yu, et al.. (2024). The Discovery of GIT1/β-Pix Inhibitors: Virtual Screening and Biological Evaluation of New Small-molecule Compounds with Anti-invasion Effect in Gastrointestinal Neoplasms. Drug Design Development and Therapy. Volume 18. 3075–3088. 1 indexed citations
10.
11.
Yuan, Weifeng, Ting Lv, Weiwei Jiang, et al.. (2023). Antigenic Characterization of Infectious Bronchitis Virus in the South China during 2021–2022. Viruses. 15(6). 1273–1273. 3 indexed citations
12.
Chen, Libin, Weiwei Jiang, Siyuan Zhang, et al.. (2023). Insights into the Epidemiology, Phylodynamics, and Evolutionary Changes of Lineage GI-7 Infectious Bronchitis Virus. Transboundary and Emerging Diseases. 2023. 1–13. 6 indexed citations
13.
Zhou, Xin, Zheng Zhang, Weiwei Jiang, et al.. (2022). Naringenin is a Potential Anabolic Treatment for Bone Loss by Modulating Osteogenesis, Osteoclastogenesis, and Macrophage Polarization. Frontiers in Pharmacology. 13. 872188–872188. 21 indexed citations
14.
Wang, Chenkun, Si Chen, & Weiwei Jiang. (2022). Treatment for chemotherapy-induced peripheral neuropathy: A systematic review of randomized control trials. Frontiers in Pharmacology. 13. 1080888–1080888. 12 indexed citations
15.
Ding, Zhen, Kun Zhang, Fanhua Ming, et al.. (2021). Novel scheme for non-invasive gut bioinformation acquisition with a magnetically controlled sampling capsule endoscope. Gut. 70(12). 2297–2306. 32 indexed citations
16.
Zhou, Chenyu, et al.. (2019). The effect of a selected yeast fraction on the prevention of pullorum disease and fowl typhoid in commercial breeder chickens. Poultry Science. 99(1). 101–110. 11 indexed citations
17.
Jiang, Weiwei & Yulan Liu. (2013). Role of intestinal flora in common liver diseases. 21(1). 5–6. 1 indexed citations
18.
Cen, Yanyan, Xiaoli Li, Dan Liu, et al.. (2012). Development and validation of LC–MS/MS method for the detection and quantification of CpG oligonucleotides 107 (CpG ODN107) and its metabolites in mice plasma. Journal of Pharmaceutical and Biomedical Analysis. 70. 447–455. 20 indexed citations
19.
20.
Wang, Liangxi, Weiwei Jiang, Guofu Ding, et al.. (2007). The newly identified CpG-N ODN208 protects mice from challenge with CpG-S ODN by decreasing TNF-α release. International Immunopharmacology. 7(5). 646–655. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ravindra P. Veeranna Breakdown of academic impact, for papers by Rui Lin Breakdown of academic impact, for papers by Yeji Kim Breakdown of academic impact, for papers by Yinglei Miao Breakdown of academic impact, for papers by Helieh S. Oz Breakdown of academic impact, for papers by Liya Yang Breakdown of academic impact, for papers by Luis Fontana Breakdown of academic impact, for papers by Lanlan Geng Breakdown of academic impact, for papers by Woo Sik Kim Breakdown of academic impact, for papers by Rohit Gundamaraju
Rankless by CCL
2026